Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatrist.com
In an insightful study on major depressive disorder, it was found that an increase in guideline concordance, as measured by the GCA-8 score, was associated with a notable improvement in patient-reported depression symptoms, emphasizing the need for rigorous adherence to established treatment protocols.
Psychiatry January 17th 2024
Psychiatry Advisor
Escitalopram shows promising results in the acute phase treatment of major depressive disorder, offering a potentially more effective and tolerable option for patients compared to other SSRIs and newer antidepressants.
The New England Journal of Medicine
Explore the pivotal role of wearable technology in advancing psychiatric care for depression, where objective data from these devices aid in tailoring individualized treatment plans and monitoring patient progress.
Psychiatry January 8th 2024
Johns Hopkins Medicine
Groundbreaking research reveals ketamine’s potential as an effective alternative to ECT in treating treatment-resistant depression, offering new hope to millions.
Psychiatry January 3rd 2024
Cancer Therapy Advisor
The mental health of cancer patients is an often overlooked aspect of their care. With anxiety and depression being significantly more prevalent in this group, it’s time we pay attention.
Oncology, Medical January 2nd 2024
Psych Congress Network
The advent of zuranolone may be going beyond postpartum depression, with 87.5% of patients noticing improvements within the first week of treatment for MDD.
Psychiatry November 14th 2023